People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Other Technology, Pharmaceuticals, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NCP Holding Co | — | Other Technology | Series B | $38.3M | $1.2B | 2012 |
| Areva Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $8.0M | $16.8M | — |
| Cardamom Health, Inc. | — | Healthtech | Seed | $1.5M | $7.9M | 2024 |
Vivek Swaminathan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vivek Swaminathan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Bakken | 1 | 24 |
| David Tamburri | 1 | 10 |
| Peter Grua | 1 | 7 |
| Darren Black | 1 | 6 |
| Frank Russell | 1 | 2 |
| Roger Natarajan | 1 | 1 |
| Irene Swaminathan | 1 | 1 |
| Yoosang Kang | 1 | 1 |
| Kenneth Christman | 1 | 1 |
| Drew Madden | 1 | 1 |
| Eric Sampson | 1 | 1 |
| David Bernd | 1 | 1 |
| Saudha Parthasarathy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.